A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

September 29, 2025

Study Completion Date

September 29, 2025

Conditions

Healthy Participants

Interventions

DRUG

AZD4144

AZD4144 will be administered orally as per arms they have been assigned.

DRUG

Placebo

Placebo will be administered orally as per arms they have been assigned.

Trial Locations (1)

Research Site, Berlin